Close

BioTelemetry (BEAT) Tops Q4 EPS by 4c

February 17, 2016 4:20 PM EST

BioTelemetry (NASDAQ: BEAT) reported Q4 EPS of $0.15, $0.04 better than the analyst estimate of $0.11. Revenue for the quarter came in at $46.8 million versus the consensus estimate of $45.89 million.

For earnings history and earnings-related data on BioTelemetry (BEAT) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings